Subclassifying Chronic Fatigue Syndrome through Exercise Testing.
Subclassifying Chronic Fatigue Syndrome through Exercise Testing. Read More »
VanNess JM et al. (2003) Subclassifying Chronic Fatigue Syndrome through […]
Research Papers
A new approach to find biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) by single-cell Raman micro-spectroscopy.
Xu J et al RSC, Analyst, 144 (3): 913-920.
Differential Effects of Exercise on fMRI of the Midbrain Ascending Arousal Network Nuclei in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) and Gulf War Illness (GWI) in a Model of Postexertional Malaise (PEM).
Baraniuk JN et al. (2022) Differential Effects of Exercise on
Elevated Perceived Exertion in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: A Meta-analysis.
Barhost EE et al. (2020)Elevated Perceived Exertion in People with
Pain-related post-exertional malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia: A systematic review and three-level meta-analysis.
Barhost EE et al. (2022) Pain-related post-exertional malaise in Myalgic
Stress-Induced Transcriptomic Changes in Females with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Reveal Disrupted Immune Signatures.
Van Booven DJ et al . (2023) Stress-Induced Transcriptomic Changes
Predicting post-exertional malaise in Gulf War Illness based on acute exercise responses.
Boruch AE et al. (2021) Predicting post-exertional malaise in Gulf
Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing.
Bouquet J et al. (2019) Whole blood human transcriptome and
Meta-analysis investigating post-exertional malaise between patients and controls.
Meta-analysis investigating post-exertional malaise between patients and controls. Read More »
Brown A and Jason LA (2020) Meta-analysis investigating post-exertional malaise
Numeric Rating Scales Show Prolonged Post-exertional Symptoms After Orthostatic Testing of Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
van Campen CLMC et al. (2021) Numeric Rating Scales Show
Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey.
Chu L et al. (2018) Deconstructing post-exertional malaise in myalgic
Neural consequences of post-exertion malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Cook DB et al. (2017) Neural consequences of post-exertion malaise
Lessons from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome for Long COVID: Postexertional Symptom Exacerbation is an Abnormal Response to Exercise/Activity.
Davenport TE et al. (2022) Lessons from Myalgic Encephalomyelitis/Chronic Fatigue
Lessons from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome for Long COVID Part 2: Physiological Characteristics During Acute Exercise Are Abnormal in People With Postexertional Symptom Exacerbation.
Davenport TE et al. (2022) Lessons from Myalgic Encephalomyelitis/Chronic Fatigue
Emotional conflict processing in adolescent chronic fatigue syndrome: A pilot study using functional magnetic resonance imaging.
Wortinger LA et al. (2017) Emotional conflict processing in adolescent
Heterogeneity of serum tryptophan concentration and availability to the brain in patients with the chronic fatigue syndrome.
Badawy AAB et al. (2005) Heterogeneity of serum tryptophan concentration
The variation of the 5-hydroxytryptamine system between chronic unpredictable mild stress rats and chronic fatigue syndrome rats induced by forced treadmill running.
Cao Y and Li Q. (2017) The variation of the
Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C] WAY-100635.
Cleare AJ ,, et al. (2005) Brain 5-HT1A receptor binding
Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
Domingo JC et al. (2021) Are Circulating Fibroblast Growth Factor